Vivos Therapeutics CEO R. Kirk Huntsman to Present at Life Sciences Conference

Vivos Therapeutics will present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference in New York City. Founder and CEO R. Kirk Huntsman will speak on behalf of the medical technology company, which specializes in treating obstructive sleep apnea and related breathing disorders Northern News.
Vivos will hold the presentation at The Westin New York Grand Central, with management available for one-on-one investor meetings throughout the event Paris Star Online. Institutional investors can schedule meetings by contacting their Moody Capital Solutions representative or reaching out to Vivos directly.
Vivos specializes in diagnosing and treating obstructive sleep apnea (OSA), a serious condition where breathing repeatedly stops during sleep Seaforth Huron Expositor. The company combines medical technology with healthcare services to address sleep and breathing disorders that affect millions of people.
The Moody Capital Solutions conference brings together life sciences companies and institutional investors seeking growth opportunities Daily Herald Tribune. The New York City event provides a platform for healthcare innovators to showcase their work and connect with potential funding partners.
Publishers
6
Articles
6
Reach
6